Trials / Conditions / Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
3 registered clinical trials studyying Philadelphia Chromosome Positive Acute Lymphocytic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-tran NCT03624530 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive NCT01883219 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Completed | Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia NCT00154349 | Novartis Pharmaceuticals | Phase 2 |